Medifast Statistics
Share Statistics
Medifast has 10.94M shares outstanding. The number of shares has increased by 0.39% in one year.
| Shares Outstanding | 10.94M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 10.61M |
| Failed to Deliver (FTD) Shares | 4 |
| FTD / Avg. Volume | 0% |
Short Selling Information
The latest short interest is 1.41M, so 12.9% of the outstanding shares have been sold short.
| Short Interest | 1.41M |
| Short % of Shares Out | 12.9% |
| Short % of Float | 13.29% |
| Short Ratio (days to cover) | 6.34 |
Valuation Ratios
The PE ratio is 7.36 and the forward PE ratio is 64.7.
| PE Ratio | 7.36 |
| Forward PE | 64.7 |
| PS Ratio | 0.68 |
| Forward PS | 0.3 |
| PB Ratio | 3.63 |
| P/FCF Ratio | 5.18 |
| PEG Ratio | n/a |
Enterprise Valuation
Medifast Inc. has an Enterprise Value (EV) of 659.19M.
| EV / Earnings | 6.63 |
| EV / Sales | 0.61 |
| EV / EBITDA | 4.73 |
| EV / EBIT | 5.22 |
| EV / FCF | 4.67 |
Financial Position
The company has a current ratio of 2.43, with a Debt / Equity ratio of 0.03.
| Current Ratio | 2.43 |
| Quick Ratio | 1.84 |
| Debt / Equity | 0.03 |
| Total Debt / Capitalization | 2.84 |
| Cash Flow / Debt | 25.09 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0.49% and return on capital (ROIC) is 43.66%.
| Return on Equity (ROE) | 0.49% |
| Return on Assets (ROA) | 0.32% |
| Return on Capital (ROIC) | 43.66% |
| Revenue Per Employee | 1.69M |
| Profits Per Employee | 156.81K |
| Employee Count | 634 |
| Asset Turnover | 3.46 |
| Inventory Turnover | 5.43 |
Taxes
| Income Tax | 29.38M |
| Effective Tax Rate | 0.23 |
Stock Price Statistics
The stock price has increased by -72.59% in the last 52 weeks. The beta is 1.16, so Medifast 's price volatility has been higher than the market average.
| Beta | 1.16 |
| 52-Week Price Change | -72.59% |
| 50-Day Moving Average | 18.42 |
| 200-Day Moving Average | 21.34 |
| Relative Strength Index (RSI) | 30.51 |
| Average Volume (20 Days) | 218.19K |
Income Statement
In the last 12 months, Medifast had revenue of 1.07B and earned 99.42M in profits. Earnings per share was 9.13.
| Revenue | 1.07B |
| Gross Profit | 775.85M |
| Operating Income | 126.40M |
| Net Income | 99.42M |
| EBITDA | 139.51M |
| EBIT | 126.40M |
| Earnings Per Share (EPS) | 9.13 |
Balance Sheet
The company has 94.44M in cash and 22.01M in debt, giving a net cash position of 72.43M.
| Cash & Cash Equivalents | 94.44M |
| Total Debt | 22.01M |
| Net Cash | 72.43M |
| Retained Earnings | 174.65M |
| Total Assets | 291.24M |
| Working Capital | 152.60M |
Cash Flow
In the last 12 months, operating cash flow was 147.66M and capital expenditures -6.48M, giving a free cash flow of 141.17M.
| Operating Cash Flow | 147.66M |
| Capital Expenditures | -6.48M |
| Free Cash Flow | 141.17M |
| FCF Per Share | 12.97 |
Margins
Gross margin is 72.37%, with operating and profit margins of 11.79% and 9.27%.
| Gross Margin | 72.37% |
| Operating Margin | 11.79% |
| Pretax Margin | 12.01% |
| Profit Margin | 9.27% |
| EBITDA Margin | 13.01% |
| EBIT Margin | 11.79% |
| FCF Margin | 13.17% |
Dividends & Yields
MED pays an annual dividend of $4.95, which amounts to a dividend yield of 31.51%.
| Dividend Per Share | $4.95 |
| Dividend Yield | 31.51% |
| Dividend Growth (YoY) | 0% |
| Payout Ratio | 738.81% |
| Earnings Yield | 59.95% |
| FCF Yield | 84.75% |
Analyst Forecast
The average price target for MED is $17, which is 11.6% higher than the current price. The consensus rating is "Hold".
| Price Target | $17 |
| Price Target Difference | 11.6% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
Scores
| Altman Z-Score | 5.15 |
| Piotroski F-Score | 7 |